crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer

Update your browser to view ScienceDirect.

Request details:

Request ID: 8bfc3b4a6f3467dd-LAX
IP: 116.62.10.13
UTC time: 2024-09-08T04:35:23+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4